An open-label trial of theophylline for functional chest pain

Satish Sanku Chander Rao, Ranjit S. Mudipalli, Victor Mujica, Craig L. Utech, Xing Zhao, Jeffrey L. Conklin

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Visceral hypersensitivity may play a role in the pathogenesis of functional chest pain, although the underlying mechanism(s) is unknown. We investigated the effects of theophylline, an adenosine receptor antagonist, on sensory perception and biomechanical properties of esophagus in patients with functional chest pain. Esophageal balloon distention was performed using impedance planimetry in 21 consecutive patients with functional chest pain. Patients found to have a hypersensitive esophagus received intravenous theophylline and balloon distension was repeated. If the hypersensitivity improved, oral theophylline was prescribed for three months as an open label trial. Balloon distension reproduced typical chest pain in 16 (76%) patients at thresholds suggestive of hypersensitivity. After theophylline infusion, pain thresholds increased in 12 (75%) patients. Median threshold pressures for discomfort and pain improved (P < 0.01). Cross-sectional area increased (P < 0.05) and the tension/strain association shifted to the right (P < 0.01). Seven of eight patients reported sustained improvement in pain after oral theophylline. Theophylline may ameliorate chest pain in patients with hypersensitive esophagus, possibly by altering adenosine-mediated nociception.

Original languageEnglish (US)
Pages (from-to)2763-2768
Number of pages6
JournalDigestive Diseases and Sciences
Volume47
Issue number12
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

Fingerprint

Theophylline
Chest Pain
Esophagus
Hypersensitivity
Purinergic P1 Receptor Antagonists
Pain
Pain Threshold
Nociception
Electric Impedance
Adenosine
Pressure

Keywords

  • Adenosine receptor antagonism
  • Esophageal hypersensitivity
  • Functional chest pain
  • Theophylline

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Rao, S. S. C., Mudipalli, R. S., Mujica, V., Utech, C. L., Zhao, X., & Conklin, J. L. (2002). An open-label trial of theophylline for functional chest pain. Digestive Diseases and Sciences, 47(12), 2763-2768. https://doi.org/10.1023/A:1021017524660

An open-label trial of theophylline for functional chest pain. / Rao, Satish Sanku Chander; Mudipalli, Ranjit S.; Mujica, Victor; Utech, Craig L.; Zhao, Xing; Conklin, Jeffrey L.

In: Digestive Diseases and Sciences, Vol. 47, No. 12, 01.12.2002, p. 2763-2768.

Research output: Contribution to journalArticle

Rao, SSC, Mudipalli, RS, Mujica, V, Utech, CL, Zhao, X & Conklin, JL 2002, 'An open-label trial of theophylline for functional chest pain', Digestive Diseases and Sciences, vol. 47, no. 12, pp. 2763-2768. https://doi.org/10.1023/A:1021017524660
Rao, Satish Sanku Chander ; Mudipalli, Ranjit S. ; Mujica, Victor ; Utech, Craig L. ; Zhao, Xing ; Conklin, Jeffrey L. / An open-label trial of theophylline for functional chest pain. In: Digestive Diseases and Sciences. 2002 ; Vol. 47, No. 12. pp. 2763-2768.
@article{1f3957ee9f694feeb8ff3f8fa5f89306,
title = "An open-label trial of theophylline for functional chest pain",
abstract = "Visceral hypersensitivity may play a role in the pathogenesis of functional chest pain, although the underlying mechanism(s) is unknown. We investigated the effects of theophylline, an adenosine receptor antagonist, on sensory perception and biomechanical properties of esophagus in patients with functional chest pain. Esophageal balloon distention was performed using impedance planimetry in 21 consecutive patients with functional chest pain. Patients found to have a hypersensitive esophagus received intravenous theophylline and balloon distension was repeated. If the hypersensitivity improved, oral theophylline was prescribed for three months as an open label trial. Balloon distension reproduced typical chest pain in 16 (76{\%}) patients at thresholds suggestive of hypersensitivity. After theophylline infusion, pain thresholds increased in 12 (75{\%}) patients. Median threshold pressures for discomfort and pain improved (P < 0.01). Cross-sectional area increased (P < 0.05) and the tension/strain association shifted to the right (P < 0.01). Seven of eight patients reported sustained improvement in pain after oral theophylline. Theophylline may ameliorate chest pain in patients with hypersensitive esophagus, possibly by altering adenosine-mediated nociception.",
keywords = "Adenosine receptor antagonism, Esophageal hypersensitivity, Functional chest pain, Theophylline",
author = "Rao, {Satish Sanku Chander} and Mudipalli, {Ranjit S.} and Victor Mujica and Utech, {Craig L.} and Xing Zhao and Conklin, {Jeffrey L.}",
year = "2002",
month = "12",
day = "1",
doi = "10.1023/A:1021017524660",
language = "English (US)",
volume = "47",
pages = "2763--2768",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - An open-label trial of theophylline for functional chest pain

AU - Rao, Satish Sanku Chander

AU - Mudipalli, Ranjit S.

AU - Mujica, Victor

AU - Utech, Craig L.

AU - Zhao, Xing

AU - Conklin, Jeffrey L.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Visceral hypersensitivity may play a role in the pathogenesis of functional chest pain, although the underlying mechanism(s) is unknown. We investigated the effects of theophylline, an adenosine receptor antagonist, on sensory perception and biomechanical properties of esophagus in patients with functional chest pain. Esophageal balloon distention was performed using impedance planimetry in 21 consecutive patients with functional chest pain. Patients found to have a hypersensitive esophagus received intravenous theophylline and balloon distension was repeated. If the hypersensitivity improved, oral theophylline was prescribed for three months as an open label trial. Balloon distension reproduced typical chest pain in 16 (76%) patients at thresholds suggestive of hypersensitivity. After theophylline infusion, pain thresholds increased in 12 (75%) patients. Median threshold pressures for discomfort and pain improved (P < 0.01). Cross-sectional area increased (P < 0.05) and the tension/strain association shifted to the right (P < 0.01). Seven of eight patients reported sustained improvement in pain after oral theophylline. Theophylline may ameliorate chest pain in patients with hypersensitive esophagus, possibly by altering adenosine-mediated nociception.

AB - Visceral hypersensitivity may play a role in the pathogenesis of functional chest pain, although the underlying mechanism(s) is unknown. We investigated the effects of theophylline, an adenosine receptor antagonist, on sensory perception and biomechanical properties of esophagus in patients with functional chest pain. Esophageal balloon distention was performed using impedance planimetry in 21 consecutive patients with functional chest pain. Patients found to have a hypersensitive esophagus received intravenous theophylline and balloon distension was repeated. If the hypersensitivity improved, oral theophylline was prescribed for three months as an open label trial. Balloon distension reproduced typical chest pain in 16 (76%) patients at thresholds suggestive of hypersensitivity. After theophylline infusion, pain thresholds increased in 12 (75%) patients. Median threshold pressures for discomfort and pain improved (P < 0.01). Cross-sectional area increased (P < 0.05) and the tension/strain association shifted to the right (P < 0.01). Seven of eight patients reported sustained improvement in pain after oral theophylline. Theophylline may ameliorate chest pain in patients with hypersensitive esophagus, possibly by altering adenosine-mediated nociception.

KW - Adenosine receptor antagonism

KW - Esophageal hypersensitivity

KW - Functional chest pain

KW - Theophylline

UR - http://www.scopus.com/inward/record.url?scp=0036912036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036912036&partnerID=8YFLogxK

U2 - 10.1023/A:1021017524660

DO - 10.1023/A:1021017524660

M3 - Article

C2 - 12498299

AN - SCOPUS:0036912036

VL - 47

SP - 2763

EP - 2768

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 12

ER -